Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kit signal transduction.

M L Taylor1, D D Metcalfe

  • 1Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Hematology/Oncology Clinics of North America
|July 26, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Forensic intelligence in Australia and New Zealand: Status and future directions.

Forensic science international·2024
Same author

Waking up on the wrong side of the bed: Depression severity moderates daily associations between sleep duration and morning affect.

Journal of sleep research·2023
Same author

Evolving the narrative for protecting a rapidly changing ocean, post-COVID-19.

Aquatic conservation : marine and freshwater ecosystems·2020
Same author

Analyses of the genetic diversity and population structures of Histoplasma capsulatum clinical isolates from Mexico, Guatemala, Colombia and Argentina, using a randomly amplified polymorphic DNA-PCR assay.

Epidemiology and infection·2019
Same author

Identification of alpha-gal sensitivity in patients with a diagnosis of idiopathic anaphylaxis.

Allergy·2017
Same author

Invertebrate population genetics across Earth's largest habitat: The deep-sea floor.

Molecular ecology·2017
Same journal

Palliative Therapy for Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Ablative Therapies for Liver Tumors.

Hematology/oncology clinics of North America·2026
Same journal

Pathology of Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery for Liver and Biliary Tract Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Surgical Considerations for Primary Liver Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and Immunotherapy.

Hematology/oncology clinics of North America·2026
See all related articles

Activating mutations in kit signaling enhance cellular responses and can lead to factor-independent activation. Understanding these mutations is crucial for mastocytosis pathogenesis and developing targeted therapies.

Area of Science:

  • Cellular Biology
  • Molecular Signaling
  • Cancer Pathogenesis

Background:

  • Kit signaling involves complex, interacting protein networks, not simple linear pathways.
  • Cytoplasmic signaling proteins form interconnected networks with cross-connections distal to the receptor.
  • Activating mutations in kit signaling are not fully understood but may enhance signaling and induce factor-independent activation.

Purpose of the Study:

  • To investigate the impact of activating mutations on kit signaling pathways.
  • To elucidate the mechanisms by which activating mutations affect kit signaling.
  • To understand the role of kit signaling mutations in mastocytosis pathogenesis and therapeutic strategies.

Main Methods:

  • Analysis of protein-protein interactions within the kit signaling network.

Related Experiment Videos

  • Investigation of the effects of specific activating mutations on kit signaling.
  • Examination of regulatory mechanisms, including phosphatases and juxtamembrane inhibitory factors.

    • Main Results:

    • Activating mutations can enhance kit signaling and promote factor-independent activation.
    • Mechanisms include potential degradation of SHP-1 (a negative regulator) and suppression of juxtamembrane inhibitory factors.
    • Kit signaling networks integrate multiple signals for coherent cellular responses.

    Conclusions:

    • Understanding activating kit mutations is vital for comprehending mastocytosis pathogenesis.
    • This knowledge forms a basis for developing more effective therapeutic interventions for mastocytosis.
    • Kit signaling complexity highlights the need for network-level analysis in disease research.